Scimago Journal & Country Rank

You must have one of these extentions in you browser

AdBlock, AdBlock Plus, uBlock Origin or others
  1. Go to your browser extentions and click the Ad blocker icon
  2. Select pause on this site, don't run on pages on this site, or some other similar option.
  3. Now you can refresh the page

Clinical Immunology Communicationsopen access

Country

United States

Universities and research institutions in United States
Media Ranking in United States

Subject Area and Category

Publisher

Elsevier Inc.

SJR 2024

0.302 Q4

H-Index

5

Publication type

Journals

ISSN

27726134

Coverage

2021-2025

Information

Homepage

How to publish in this journal

Scope

Clinical Immunology Communications is a new online only, open-access journal that publishes high-quality, peer-reviewed contributions in the evolving areas of clinical immunology. The journal considers submissions transferred from Clinical Immunology, as well as direct submissions on basic, translational and clinical studies in vitro and in vivo in animal models and in humans, to advance the understanding of cellular, biochemical and molecular aspects of clinical immunology for broad audiences. The ultimate goal of Clinical Immunology Communications is to provide readers with new information on a wide range of clinical immunology subjects including: (1) autoimmune diseases; (2) hypersensitivity and allergy; (3) tumor immunology; (4) immunodeficiencies; (5) immunity to infection including HIV; (6) vaccines; (7) transplantation; (8) new immunological methods and techniques. The types of manuscripts considered for publication will include: (1) original articles; (2) brief communications; (3) reviews; (4) case reports or case cohorts; (5) editorials (by invitation only); (6) guidelines (written by academic authorities and focusing on clinical diagnosis and/or treatment, or use of methodologies in clinical immunology). Join the conversation about this journal
Quartiles

The set of journals have been ranked according to their SJR and divided into four equal groups, four quartiles. Q1 (green) comprises the quarter of the journals with the highest values, Q2 (yellow) the second highest values, Q3 (orange) the third highest values and Q4 (red) the lowest values.

CategoryYearQuartile
Immunology2024Q4
Immunology and Allergy2024Q4
SJR

The SJR is a size-independent prestige indicator that ranks journals by their 'average prestige per article'. It is based on the idea that 'all citations are not created equal'. SJR is a measure of scientific influence of journals that accounts for both the number of citations received by a journal and the importance or prestige of the journals where such citations come from It measures the scientific influence of the average article in a journal, it expresses how central to the global scientific discussion an average article of the journal is.

YearSJR
20240.302
Total Documents

Evolution of the number of published documents. All types of documents are considered, including citable and non citable documents.

YearDocuments
20218
202231
202326
202415
Citations per document

This indicator counts the number of citations received by documents from a journal and divides them by the total number of documents published in that journal. The chart shows the evolution of the average number of times documents published in a journal in the past two, three and four years have been cited in the current year. The two years line is equivalent to journal impact factor ™ (Thomson Reuters) metric.

Cites per documentYearValue
Cites / Doc. (4 years)20210.000
Cites / Doc. (4 years)20221.250
Cites / Doc. (4 years)20231.282
Cites / Doc. (4 years)20240.846
Cites / Doc. (3 years)20210.000
Cites / Doc. (3 years)20221.250
Cites / Doc. (3 years)20231.282
Cites / Doc. (3 years)20240.846
Cites / Doc. (2 years)20210.000
Cites / Doc. (2 years)20221.250
Cites / Doc. (2 years)20231.282
Cites / Doc. (2 years)20240.825
Total Cites 
Self-Cites

Evolution of the total number of citations and journal's self-citations received by a journal's published documents during the three previous years.
Journal Self-citation is defined as the number of citation from a journal citing article to articles published by the same journal.

CitesYearValue
Self Cites20210
Self Cites20222
Self Cites202314
Self Cites20241
Total Cites20210
Total Cites202210
Total Cites202350
Total Cites202455
External Cites per Doc 
Cites per Doc

Evolution of the number of total citation per document and external citation per document (i.e. journal self-citations removed) received by a journal's published documents during the three previous years. External citations are calculated by subtracting the number of self-citations from the total number of citations received by the journal’s documents.

CitesYearValue
External Cites per document20210
External Cites per document20221.000
External Cites per document20230.923
External Cites per document20240.831
Cites per document20210.000
Cites per document20221.250
Cites per document20231.282
Cites per document20240.846
% International Collaboration

International Collaboration accounts for the articles that have been produced by researchers from several countries. The chart shows the ratio of a journal's documents signed by researchers from more than one country; that is including more than one country address.

YearInternational Collaboration
202112.50
202219.35
202330.77
202440.00
Citable documents 
Non-citable documents

Not every article in a journal is considered primary research and therefore "citable", this chart shows the ratio of a journal's articles including substantial research (research articles, conference papers and reviews) in three year windows vs. those documents other than research articles, reviews and conference papers.

DocumentsYearValue
Non-citable documents20210
Non-citable documents20221
Non-citable documents20231
Non-citable documents20242
Citable documents20210
Citable documents20227
Citable documents202338
Citable documents202463
Cited documents 
Uncited documents

Ratio of a journal's items, grouped in three years windows, that have been cited at least once vs. those not cited during the following year.

DocumentsYearValue
Uncited documents20210
Uncited documents20224
Uncited documents202314
Uncited documents202436
Cited documents20210
Cited documents20224
Cited documents202325
Cited documents202429
% Female Authors

Evolution of the percentage of female authors.

YearFemale Percent
202145.71
202251.05
202353.98
202438.96
Documents cited by public policy (Overton)

Evolution of the number of documents cited by public policy documents according to Overton database.

DocumentsYearValue
Overton20210
Overton20220
Overton20230
Overton20240
Documents related to SDGs (UN)

Evolution of the number of documents related to Sustainable Development Goals defined by United Nations. Available from 2018 onwards.

DocumentsYearValue
SDG20210
SDG20220
SDG20230
SDG20248
Estimated APC

It estimates the article processing charges (APCs) a journal might charge, based on its visibility, prestige, and impact as measured by the SJR. It does not reflect the actual APC, but rather a calculated approximation based on journal quality.

YearEst. APC (USD)
2021
2022
2023
20242670
Estimated financial value

It represents the potential financial worth of a journal. It is obtained by multiplying the journal's Estimated APC by the total number of citable documents published over the past five years. This value reflects the hypothetical revenue a journal could generate based on its estimated publication costs and scholarly output.

YearEst. value (USD)
2021
2022
2023
202440045
Scimago Journal & Country Rank
Show this widget in your own website

Just copy the code below and paste within your html code:
SCImago Graphica
Explore, visually communicate and make sense of data with our new data visualization tool.
Metrics based on Scopus® data as of March 2025
Loading comments…

Leave a comment

* Required

* Required

* Required

* Required

The users of Scimago Journal & Country Rank have the possibility to dialogue through comments linked to a specific journal. The purpose is to have a forum in which general doubts about the processes of publication in the journal, experiences and other issues derived from the publication of papers are resolved. For topics on particular articles, maintain the dialogue through the usual channels with your editor.

Developed by:
Scimago Lab
Powered by:
Powered by scopus

Follow us on @ScimagoJR

Scimago Lab, Copyright 2007-2025. Data Source: Scopus®

Legal Notice

Privacy Policy